4.7 Article

Simultaneous tritium labelling of two potent 5-HT4 ligands

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 45, 期 3, 页码 1263-1265

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2009.12.012

关键词

Tritium; Radiolabelling; Radioligand; 5-HT4; Serotonin-4 receptors

向作者/读者索取更多资源

Two potent and selective 5-HT4 ligands, [H-3]-5-[(N-propylpiperidin-4-yl)methoxy]-1,2,3,4-tetrahydrobenzo[h][1,6] naphthyricline (1a) and [H-3]-1-methyl-5-[(N-propylpiperidin-4-yl)methoxy]pyrrolo[1,2-a]thieno[2,3-e]pyrazine (2a) were radiolabelled with tritium. Radioactive labelling was achieved by Simultaneous tritium reduction of a mixture of both propargylic precursors (1c-2c). The two tritiated ligands thus obtained were radiochemically pure and possessed high radioactive specific activities. These tritiated 5-HT4 ligands will allow for binding characterization as an essential tool for their further development. (C) 2009 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Synthesis, evaluation and metabolic studies of radiotracers containing a 4-(4-[18[F]-fluorobenzyl)piperidin-1-yl moiety for the PET imaging of NR2B NMDA receptors

Romain Labas, Gwenaelle Gilbert, Olivier Nicole, Martine Dhilly, Ahmed Abbas, Olivier Tirel, Alain Buisson, Joel Henry, Louisa Barre, Daniele Debruyne, Franck Sobrio

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)

Article Chemistry, Medicinal

Synthesis and in vitro characterization of trans- and cis-[18F]-4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]-3-fluoropiperidine-1-carboxylates as new potential PET radiotracer candidates for the NR2B subtype N-methyl-D-aspartate receptor

Radouane Koudih, Gwenaelle Gilbert, Martine Dhilly, Ahmed Abbas, Louisa Barre, Daniele Debruyne, Franck Sobrio

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Biochemical Research Methods

Radiosynthesis of N-[4-(4-fluorobenzyl)piperidin-1-yl]-N '-(2-[C-11]oxo-1,3-dihydrobenzimidazol-5-yl)oxamide, a NR2B-selective NMDA receptor antagonist

Romain Labas, Franck Sobrio, Yann Bramoulle, Anne-Sophie Herard, Martine Guillermier, Philippe Hantraye, Frederic Dolle, Louisa Barre

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2010)

Review Biochemical Research Methods

Radiosynthesis of carbon-11 and fluorine-18 labelled radiotracers to image the ionotropic and metabotropic glutamate receptors

Franck Sobrio

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2013)

Review Chemistry, Medicinal

PET and SPECT Imaging of the NMDA Receptor System: An Overview of Radiotracer Development

F. Sobrio, G. Gilbert, C. Perrio, L. Barre, D. Debruyne

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Automated Radiosynthesis of [18F]ML-10, a PET Radiotracer Dedicated to Apoptosis Imaging, on a TRACERLab FX-FN Module

Franck Sobrio, Marie Medoc, Ludovic Martial, Jerome Delamare, Louisa Barre

MOLECULAR IMAGING AND BIOLOGY (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Complementary information from magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model

Samuel Valable, Edwige Petit, Simon Roussel, Lena Marteau, Jerome Toutain, Didier Divoux, Franck Sobrio, Jerome Delamare, Louisa Barre, Myriam Bernaudin

NUCLEAR MEDICINE AND BIOLOGY (2011)

Article Chemistry, Organic

Radiolabelling of 1,4-disubstituted 3-[18F]fluoropiperidines and its application to new radiotracers for NR2B NMDA receptor visualization

Radouane Koudih, Gwenaelle Gilbert, Martine Dhilly, Ahmed Abbas, Louisa Barre, Daniele Debruyne, Franck Sobrio

ORGANIC & BIOMOLECULAR CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

A new class of fluorinated 5-pyrrolidinylsulfonyl isatin caspase inhibitors for PET imaging of apoptosis

Anwen M. Krause-Heuer, Nicholas R. Howell, Lidia Matesic, Geetanjali Dhand, Emma L. Young, Leena Burgess, Cathy D. Jiang, Nigel A. Lengkeek, Christopher J. R. Fookes, Tien Q. Pham, Franck Sobrio, Ivan Greguric, Benjamin H. Fraser

MEDCHEMCOMM (2013)

Article Chemistry, Multidisciplinary

Nucleophilic radiofluorination at room temperature via aziridinium intermediates

M. Medoc, F. Sobrio

RSC ADVANCES (2014)

Meeting Abstract Biochemical Research Methods

Automated radiosynthesis and control quality of [18F]ML-10, a radiopharmaceutical to image the apoptosis

Franck Sobrio, Marie Medoc, Louisa Barre

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2013)

Meeting Abstract Biochemical Research Methods

Nucleophilic radiofluorination at room temperature via aziridiniums

Marie Medoc, Franck Sobrio

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2013)

Meeting Abstract Biochemical Research Methods

Development of the 4-substituted-3-[18F]fluoropiperidine pattern and its use for the radiolabelling ofa NR2B NMDA antagonist

Radouane Koudih, Gwenaelle Gilbert, Ahmed Abbas, Martine Dhilly, Louisa Barre, Daniele Debruyne, Franck Sobrio

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2011)

Meeting Abstract Biochemical Research Methods

Radiosynthesis and PET evaluation the 18F-labelled RGH-896, a NR2B NMDA receptor antagonist and metabolism study by LC/MS of the 4-(4-fluorobenzyl)piperidine moiety

Franck Sobrio, Gwenaelle Gilbert, Romain Labas, Martine Dhilly, Ahmed Abbas, Daniele Debruyne, Louisa Barre

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2011)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)